These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 37391346)

  • 1. Mouse models of sickle cell disease: Imperfect and yet very informative.
    Kamimura S; Smith M; Vogel S; Almeida LEF; Thein SL; Quezado ZMN
    Blood Cells Mol Dis; 2024 Jan; 104():102776. PubMed ID: 37391346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.
    Pradhan-Sundd T; Kato GJ; Novelli EM
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C494-C504. PubMed ID: 35759437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease in mice is associated with sensitization of sensory nerve fibers.
    Kenyon N; Wang L; Spornick N; Khaibullina A; Almeida LE; Cheng Y; Wang J; Guptill V; Finkel JC; Quezado ZM
    Exp Biol Med (Maywood); 2015 Jan; 240(1):87-98. PubMed ID: 25070860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations.
    Woodard KJ; Doerfler PA; Mayberry KD; Sharma A; Levine R; Yen J; Valentine V; Palmer LE; Valentine M; Weiss MJ
    Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35793591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice.
    Wang X; McKillop WM; Dlugi TA; Faber ML; Alvarez-Argote J; Chambers CB; Wilber A; Medin JA
    J Gene Med; 2024 Jan; 26(1):e3567. PubMed ID: 37455676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.
    Promsote W; Powell FL; Veean S; Thounaojam M; Markand S; Saul A; Gutsaeva D; Bartoli M; Smith SB; Ganapathy V; Martin PM
    Antioxid Redox Signal; 2016 Dec; 25(17):921-935. PubMed ID: 27393735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Li C; Georgakopoulou A; Newby GA; Chen PJ; Everette KA; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A
    Blood; 2023 Apr; 141(17):2085-2099. PubMed ID: 36800642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
    El Nemer W; Godard A; El Hoss S
    Curr Opin Hematol; 2021 May; 28(3):171-176. PubMed ID: 33631786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation for engraftment of CD34
    Uchida N; Li L; Nassehi T; Drysdale CM; Yapundich M; Gamer J; Haro-Mora JJ; Demirci S; Leonard A; Bonifacino AC; Krouse AE; Linde NS; Allen C; Peshwa MV; De Ravin SS; Donahue RE; Malech HL; Tisdale JF
    Cell Rep Med; 2021 Apr; 2(4):100247. PubMed ID: 33948577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base editing of haematopoietic stem cells rescues sickle cell disease in mice.
    Newby GA; Yen JS; Woodard KJ; Mayuranathan T; Lazzarotto CR; Li Y; Sheppard-Tillman H; Porter SN; Yao Y; Mayberry K; Everette KA; Jang Y; Podracky CJ; Thaman E; Lechauve C; Sharma A; Henderson JM; Richter MF; Zhao KT; Miller SM; Wang T; Koblan LW; McCaffrey AP; Tisdale JF; Kalfa TA; Pruett-Miller SM; Tsai SQ; Weiss MJ; Liu DR
    Nature; 2021 Jul; 595(7866):295-302. PubMed ID: 34079130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.
    Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.
    Vats R; Liu S; Zhu J; Mukhi D; Tutuncuoglu E; Cardenes N; Singh S; Brzoska T; Kosar K; Bamne M; Jonassaint J; Adebayo Michael A; Watkins SC; Hillery C; Ma X; Nejak-Bowen K; Rojas M; Gladwin MT; Kato GJ; Ramakrishnan S; Sundd P; Monga SP; Pradhan-Sundd T
    Hepatology; 2020 Dec; 72(6):2165-2181. PubMed ID: 32190913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 2,3-DPG knockout on SCD phenotype in Townes SCD model mice.
    Barakat A; Jasuja R; Tomlinson L; Wenzel Z; Ramaiah L; Petterson BA; Kapinos B; Sawant A; Pagan V; Lintner N; Field D; Ahn Y; Knee KM
    Am J Hematol; 2023 Dec; 98(12):1838-1846. PubMed ID: 37688507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
    Ansari J; Moufarrej YE; Pawlinski R; Gavins FNE
    Expert Rev Hematol; 2018 Jan; 11(1):45-55. PubMed ID: 29207881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep phenotype in the Townes mouse model of sickle cell disease.
    O'Donnell BJ; Guo L; Ghosh S; Shah FA; Strollo PJ; McVerry BJ; Gladwin MT; Ofori-Acquah SF; Kato GJ; O'Donnell CP
    Sleep Breath; 2019 Mar; 23(1):333-339. PubMed ID: 30159633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Porcu S; Simbula M; Marongiu MF; Perra A; Poddie D; Perseu L; Kowalik MA; Littera R; Barella S; Caria CA; Demartis FR; Ristaldi MS
    Br J Haematol; 2021 Jun; 193(6):1228-1237. PubMed ID: 34046885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.